Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Company vs Company · SEC EDGAR Data
Both ELI LILLY & Co and Telix Pharmaceuticals Ltd show comparable financial profiles across the metrics analyzed, with neither entity clearly dominating across all categories.
| Annual Revenue | $65.18B | N/A |
| Net Income | $20.64B | N/A |
| Net Margin | 31.7% | N/A |
| YoY Growth | +44.7% | N/A |
| Total Assets | $112.48B | N/A |
By annual revenue, Telix Pharmaceuticals Ltd is the larger company. ELI LILLY & Co reported $65.18B vs Telix Pharmaceuticals Ltd's N/A in annual revenue.
By net profit margin, Telix Pharmaceuticals Ltd is more profitable. ELI LILLY & Co's margin is 31.7% vs Telix Pharmaceuticals Ltd's N/A.
Both ELI LILLY & Co and Telix Pharmaceuticals Ltd show comparable financial profiles across the metrics analyzed, with neither entity clearly dominating across all categories.
Financial data sourced from SEC EDGAR 10-K annual filings. All figures in USD. Data reflects the most recently filed annual report. Not investment advice — verify with official SEC filings before financial decisions.